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Members of the integrin family of adhesion receptors 
are essential participants in blood vessel growth and 
rexnodeling. It is not known which integrins are in-
volved in the initial stages of angiogenesis in vivo. In 
this study we determined the location of integrins on 
the blood vessels of a growing tissue, the neonatal fore-
skin, in which neovascularization is likely to occur. We 
used the confocal microscope to visually reconstruct 
vessels from the papillary dermis of the foreskin and to 
identify potential sprouts as narrow, tapering exten-
sions from these vessels. Blood vessels were initially 
identified by their positive reaction with antibodies to 
von Willebrand factor or human platelet endothelial 
cell adhesion molecule and their negative response to 
anti-neurofilament antibodies. Later, vessels were 
identified by their shape and location. We screened 
A ngiogenesis, whether during development or wound healing, entails the sprouting of new vessels from pre-existing vessels. Endothelial cells extend processes through breaks in the basement membrane and then migrate as a column into the interstitial matrix. This 
migration consists of pairs of endothelial cells sliding past each 
other. Proximally the column may contain a lumen, but distally it is 
a solid cord [1-3]. 
Cell migration is a complex process requiring adhesion receptors 
to provide traction without binding cells too tightly to the sub-
stratum, and intracellular signaling to realign the cytoskeleton and 
initiate cortical flow [4]. Members of the integrin family of hetero-
dimeric transmembrane receptors are involved in cell-substratum 
and cell-cell adhesion and also initiate various intracellular signals. 
The integrins bind to extracellular matrix molecules through their 
external domain, and may directly attach to cytoskeletal elements 
(tal in and a-actinin) via their cytoplasmic domain. The ligand spec-
ificity and signaling ability of integrins are determined by varying 
the combination of a and fJ subunits that make up the heterodimers. 
There are twelve known a subunits and eight known fJ subunits. 
The integrin subunits a1, a2, a3, as, a6, fJl, fJ3, fJ4, and fJS have 
been detected on endothelial cells [5 - 9]. 
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vessels with anti bodies to integrin subunits at, a2, a3, 
as, a6, av, Pl, P3 and p4. We found that integrin sub-
units a6 and P4 were consistently found along the 
whole length of capillary loops and extended to the 
distal ends of presumed sprouts. The a2 and av integrin 
concentrations, which are normally low in the micro-
vasculature, were increased on the sprouts. as was ei-
ther absent from vessels entirely or more concentrated 
on the body than on the sprout. at was more com-
monly present on nerves than blood vessels. These 
studies suggest an important role for the a6p4 integrin 
in the initial stages of endothelial outmigration during 
new vessel growth. Key words: endothelial sproutjadhe-
sionjangiogenesisjextracellular matrix. ] Invest Dermatol 
103:381-386, 1994 
Angiogenesis obliges endothelial cells to leave the collagen IV / 
laminin-rich basement membrane and migrate through a matrix 
rich in interstitial collagen and fibronectin . We assumed that this 
change of substratum would require a different array of integrins on 
the endothelial sprout. Our purpose was to determine which inte-
grins are important in the initial stages of blood vessel growth and 
repair. To do so, we have used confocal microscopy to reconstruct 
vessels from laser sections and identify sprouts as thin cords arising 
from vessels. 
The confocal microscope, which allows the use of thick tissue 
sections (10 J1 or more are visually sectioned down to 0.5 - 1.0 J1 and 
then reconstructed by computer). has several advantageous features 
for examining sprouts. Because vessels can be studied over longer 
distances than usual. a) sprouts can be visualized, b) molecules can 
be compared by double-labeling immunofluorescence for their lo-
cation along the sprout, and c) chances of "sprout" artifacts are 
greatly decreased because serial reconstruction shows whether a 
thin strand is truly a vessel outgrowth or only part of a longer vessel. 
In addition. the thick sections diminish the possibility that a vessel 
"end" will be created by cutting off the rest of the vessel. 
We used double-labeling immunofluorescence microscopy to 
compare the location of various integrins on vessel sprouts with the 
location of the a6 integrin. The 0'6 integrin was chosen as a stan-
dard because antibodies to a6 produce intense staining of all endo-
thelial cells at blood vessel basement membranes [9], and because we 
noted that this staining appeared to extend far into sprouts. The a6 
integrin is also found on the epidermis and glands, and on infiltrat-
ing cells such as macrophages. but is not found on fibroblasts or 
smooth muscle cells by tissue staining [10]. Our studies indicate that 
integrins a6 and fJ4 are found on the narrow extensions of sprouts 
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Figure 1. Hematoxylin and eosin stain of neonatal foreskin. Arrow 
indicates capilla ry tip approaching epidermis (E). 
and may show a concentration at the distal tip. a2 and av, though 
less concentrated than a6, are also found along the sprouts. Inte-
grins as and fJ3 are more prevalent on the body of blood vessels, and 
arc entirely absent from some vessels. 
MATERIALS AND METHODS 
Tissue Preparation Human foreskin was obtained from the Well-baby 
Nursery at the University of Cali fornia San Francisco. Tissues were fi xed for 
4 h in 4% formaldehyde in phosphate-buffered saline (PBS), transferred to 
15% sucrose for 1 h, embedded in O.C.T. (Miles Laboratories, Elkhart Lake, 
Indiana), and frozen in liquid nitrogen. Tissue blocks were stored at-80·C. 
Frozen sections 10 - 18 fl thick were pl aced on superfrost glass slIdes 
(Fisher) . 
Immunofluorescent Staining All incubations and washes were done at 
room·temperature in 1% goat se rum in PBS. Nonspecific staining in tissue 
sections was blocked by incubating for 1 h in 1 % goat serum in PBS. Sections 
were then treated with primary antibodies for 20 min, rinsed five times, 
treated with secondaty antibodies conju gated to fluorescein (at 1 : 50) or 
rhodamine-lissamine (at 1 : 1000) for 20 min, washed five times, and 
mounted in Fluoromount-G (Fisher Biotech, Pittsburgh, PAl . In all cases 
shown, 0'6 was labeled with rhodamine. 
Figure 2. Expression of 0'6 on PECAM-positive vessels. Projection of 
confocal Z series. N eonatal foreskin was simultaneously labeled by indirect 
immunofluorescence with antibodies to a) the endothelial ce ll marker 
PEC AM (with fluorescein secondary) and b) the 0'6 integrin (with rhoda-
mine secondary). 0'6 is found both on blood vessels and on the dermal-epi-
dermal junction 0) . Note narrowing of vessel near tip (arrows). E, epidermis. 
Bar, 10 JIm . 
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Figure 3. Neurofilament localization in foreskin. Projection of confo-
cal Z series. A) The shape of fluorescein-labeled neurofilaments (a) is distinct 
from that of rhodamine- labeled vWF-positive blood vessels (b). Arrowheads, 
nerves. Hollow arrows, blood vessels. B) Fluorescein-labeled neurofilaments 
(a) are distinct from rhodamine-labeled 0'6 extensions (b). Arrow, tip of vessel 
extension. E, epidermis. ], dermal-epidermal junction. Bar, 10 flln . 
Antibodies Mouse anti-human 0'1 was from T-Cell Sciences, Cam-
bridge, MA. Mouse monoclonal anti-a2 (1 2Fl) was provided by Dr. Virgil 
Wood, University of Californ ia, San Diego, C A [11]. Mouse monoclonal 
anti-a3 (VM-2) was provided by Dr. Vera Morhenn, SRI International, 
Menlo Park , C A [12] . Rabbit antibody to 0'5 was provided by R. Hynes, 
MIT, Boston [13]. Rat monoclonal anti-a6 01B5) was provided by Dr. 
Caroline Damsky, U CSF, San Francisco, CA [14]. Mouse monoclonal anti-
human integrin av subunit (LM142) was provided by Dr. David Cheresb, 
Research Institute of Scripps C linic, La ]olla , CA [15]. Mouse monoclonal 
anti-human integrinpl (A-lAS) was provided by Dr. Martin Hemler, Dana 
Farber Cancer Institute, Boston, MA [16]. Rabbit antibody to human p 
(anti - GplIb- II1a) was provided by Dr. David Phillips, U CSF [17] . Mouse 
monoclonal anti-p4 (3El) and polyclonal anti-human laminin were pur-
chased from Telios Pharmaceuticals, San Diego , C A. Mouse monoclonal 
anti-epiligrin (GB3) was purchased from Accurate C hemical and Scientific 
Corporation, Westbury, NY. Polyclonal antibodies to von Willebrand fac-
tor (vWF) were purchased from Sigma C hemical, St. Louis, MO. Monoclo· 
nal antibodies to ncurofilaments (200 kDa protein) were from Boehringer 
Mannheim, Indianapolis, IN . Monoclonal antibodies to human platelet eo-
dothelial cell adhesion molecul e (PECAM) were from Rand 0 Systems, 
Minneapolis, MN . Goat anti-mouse, anti-rat and anti-rabbit IgG conjugated 
with f1uorescein-isothiocyanate and goat anti-mouse, anti-rat, and anti-rab· 
bit IgG conjugated with lissamine-rhodamine were from]ackson Immuno-
Research. W est Grove, PA. Antibodies were tested to ensure that there was 
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no crossreactivity of anti-mouse secondaty antibody with rat primary anti-
body or vice versa. 
Microscopy Samples were viewed on a Biorad MRC 600 confoca l micro-
scope and analyzed with the COMOS program. The papillary dermis was 
searched for potential vessel sprouts (areas of vessel narrowing). These areas 
were visually sectioned to 1 f-l by the microscope. The dermal-epidermal 
junction was used as a marker for determining tissue thickness. Sections were 
reconstructed into two-dimensional projections from a 1-f-l series. All micro-
graphs are projections of a Z series unless otherwise indicated. 
RESULTS 
We chose human neonatal foreskin in which to study microvascular 
development because there is significant neovascularization in skin 
during the first three postnatal months [18 - 20], and because a large 
number of probes are available for human integrins and their lig-
ands. After birth, the disorganized subpapillary plexus in the skin is 
remodeled into discrete pathways, and capillary loops are projected 
deep into the dermal papilla. Figure 1 shows a hema toxylin-and-
eosin-stained section of neonatal foresk in. Note how the capillary 
tapers as it extends towards the epidermis. 
We used both immunologic and morphologic criteria to identify 
sprouts arisi~g from the mi~rovasculature. First, blood v~ssels w.ere 
identified wlthll1 the dermiS of human foreskll1 by their reaction 
with antibodies to the endothelial cell markers vWF or PECAM. 
Sprouts were recognized as tapering continuous extensions from 
these vessels that were verified not to be fragmented vessels by 
confocal sectioning. Whereas capillaries are typically 5 - 10 I1-m in 
diameter, the sprout tips are solid cords that narrow to -2 /1m or 
sometimes have wider club-like shapes [2]. The confoca l micro-
scope allows the observer to follow vessels through a thick tissue 
block and to distinguish the top and bottom of sections of the block. 
We consider that those extensions that taper and end in the middle 
sections of a series are likely to be sprouts and not cutting artifacts. 
Our initial studies compared the location of various integrins 
with that of the blood vessel markers PECAM and vWF. Figure 2 is 
a confocal two-dimensional reconstruction of neonatal foreskin 
double-labeled for PECAM and a6 by indirect immunofluores-
cence. The blood vessel tapers until it is too narrow to contain a 
lumen. PECAM co localizes with a6 on both the vessel and the 
tapering extension. However, the dermal-epidermal junction is 
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a6-positive and PECAM-negative. Comparison of other integrins 
with PECAM or vWF confirmed previous reports [5 ,9,21] that a2, 
a3, as, av, /11 and /14 arc present on the body of some blood vessels 
of the microvasculature (not shown). 
Because a6 stains blood vessels continuously and intensely, we 
chose a6 as the standard with which to compare the location of 
other integrins. However, because a6 is also found on nerves, we 
first compared the location and appearance of nerves, as labeled by 
antibodies to the 200-kDa neurofilament protein, with that of vWF 
or a6 in the papiIJary dermis (Fig 3). Unlike the blood vessels, 
which taper into sprouts, the nerves remain very narrow over long 
distances. Sometimes the nerve fiber twists around a vessel or runs 
alongside a blood vesseL Figure 3B shows a tapering a6-positive 
vessel that does not react with anti-neurofi\ament antibodies. 
Comparison of other integrins with a6 revealed that /14 coloca-
lized on sprouts with a6 (Fig 4). Figure 4B shows part of a Z series 
of the same tissue block. Note that the narrow vessel extension is 
longest in section S and gradually diminishes in length in subse-
quent sections. Like a6, antibodies to /14 stained basement mem-
branes of endothelium and epithelium intensely. Whereas a6 and 
/14 were present along most of the vessel length, staining for both a2 
and av was pale on n1.uch of the vessel body, but was sometimes 
concentrated in the distal part of the vessel containing the sprout 
(Fig SA,B). The diffuse staining of a2 and av suggested cytoplas-
mic localization rather than the basement membrane localization of 
a6. Antibody to a2 usually stained the basal epidermal cells much 
more intensely than the blood vessels (Fig SA) whereas av staining 
was patchy or faint in the epidermis (Fig SB) . Antibody to /11, like 
that to a6, stained the full length of many vessels, but the two stains 
did not always colocalize either along the vessel or at the tip (Fig 
SC). Areas in which /11 and a6 did not colocalize likely represented 
a6/1 4-rich sites. It was also noted that staining of the epidermis with 
anti-/11 antibodi es produced a circumcellular pattern, without a dis-
tinct basement membrane stain, suggesting a lack of a6/11 on the 
basement membrane. Anti-/13 stained some vessel bodies brightly 
(Fig SD) and others not at all; it also extended along some sprouts 
(not shown). Three integrin subunits were almost never seen on 
vessel sprouts. Staining for the as integrin was either more concen-
trated on the vessel body than on tapering extensions or missing 
entirely (Fig SE) . as was only infrequently seen on epidermal 
patches. Staining for a3, which was pale on blood vessels, was 
Figure 4. Colocalization of P4 and a6 in projection ofZ series and individual Z-series sections. A) Projection of Z series. Fluorescein-labeled (l4 (a) 
colocalizes with rhodamine-labeled a6 (b). Arrow, tip of vessel extension. E, epidermis. J, dermal-epidermal junction. B) 1 J.1. sections from the Z series. Sections 
2-10 of a 12-section series are shown. Section 5 corresponds to the longest tapering extensions shown in A. Bar, 10 f-lm. 
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Figure 5. Localization of a2, av, Pl, /f3, as, and al on blood vessels. Projection of confocal Z series. Foreskin was double-labeled with fluorescein for 
either a2, av, PI, P3, as, or al and with rhodamine for a6.7'I:) a2 is prominent in basal epidermal cells and diffusely present on the end of blood vessel 
extensions (a) as compared with a6 (b). B) av is diffusely present near the vessel tip (a) as compared with a6 (b). Note the break in stainingjust before the tip on 
the a6-positive sprout. This break is characteristic of a6 in sprouts. C) PI is brightly stained along the vessel length (a) but is not always colocalized with a6 (b). 
D) p3 is present on the blood vessel body (a) lesser amounts on the vessel extension, visualized by staining a6 (b). B) as is sometimes found along blood vessell 
(a) but is less distinct on vessel extensions, as visualized by staining a6 (b). F) al is predominantly found on the nerve (a) encircling the a6-positive vessel (b). 
Epidermis in F is on the right side of picture. E, epidermis. J, dermal-epidermal junction. A rrolVs, tips of vessel extensions. Bar, 10 11m. 
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concentrated on basal epidermal cells (not shown). 0'1 was more 
prevalent on nerves than on blood vessels (Fig SF). 
We also compared the localization of 0'6 with that of its potential 
ligands: lam in in, and the laminin variant epiligrin. Epiligrin was 
usually not present on blood vessels. A-chain laminin was present on 
all a6-positive vessels, as were its individual A and B subunits (data 
not shown). 
DISCUSSION 
Using the confocal microscope to reconstruct blood vessels, we have 
examined the localization of various integrins along the vessels and 
their newly forming sprouts. The integrins 0'6 and /34 were most 
consistently found on both the body of microvascular vessels and on 
the long, tapering sprouts. Integrins 0'2 and av sometimes colo-
calized with the tips of these extensions, whereas 0'5, when present, 
was denser on the vessel body than on the distal end of the sprout. 
The known ligands for 0'6/31 and 0'6/34 are members of the la-
rninin family. The consistent localization of 0'6 and /34 at the distal 
ends of sprouts came as a surprise. because endothelial cells leave the 
laroinin/type IV collagen-rich blood vessel basement membrane 
during angiogenesis and migrate through a matrix rich in fibronec-
tin, fibrin, and interstitial collagen. However, studies of induced 
angiogenesis in corneas have ~et~c~ed laminin at the tips of new~y 
fonning vessels, and even on 1I1dlvldual cells 111 advance of the tiP 
[22,23]. When human microvascular endothelial cells are plated on 
fibwnectin itl vitro, they synthesize laminin within 24 h [23]. In 
addition, the endothelial cell line EAHY 926 forms tubes in the 
laroinin-rich matrix Matrigel. Significantly, this tube formation is 
blocked by antibodies to 0'6 or /31, but not by antibodies to 0'5. 
Blockage occurs when as few as 10% of 0'6 or /31 sites are bound by 
antibody [24]. Much higher antibody concentrations are needed to 
block cel l adhesion . Drake et al [25] provided evidence that an earlier 
stage of angiogenesis, cord formation, is not dependent on /31 inte-
grins . They showed that when chick embryos are treated with the 
CSA T antibody, which perturbs /31 integrins, formation of blood 
vessel tubes from so lid cords is blocked, but initial cord formation is 
unaffected. Therefore, if integrins function in cord formation ill 
vivo, one would expect that a major component would be some 
non-til integrin, such as /34. 
0'6/34 is primarily associated with epiligrin in hemidesmosome 
complexes on epithelial cells [26) . However, well-developed hemi-
desmosomes are not present in the microvasculature. Because epili-
grin (A. Sonne~berg, personal. communication) and A-chain la-
minin [27] are lIgands of 0'6/34 111 other cell types, we attempted to 
stain for epiligrin with GB3 antibodies. Results were usually nega-
tive. Either epiligrin is not present or microvascular epiligrin is not 
accessible to the GB3 antibodies. A third possibility is that a variant 
epiligrin-like laminin isoform exists that could bind 0'6/34. In fact, a 
truncated variant of laminin has been detected in aortic endothelial 
cells [28]. We have observed that dermal microvascular endothelial 
cells do not make significant A-chain laminin, but seem to synthe-
size a truncated form of laminin (unpublished observations). 
AI though 0'6 and /34 were present along the whole length of the 
vessel and sprout, 0'2 and O'v staining was relatively weak along the 
vessel body and was sometimes detectable only on the distal end of 
the vessel, including the sprout. The increased density of 0'2 and O'v 
on vessel sprouts is evidence that they are active in angiogenesis. 
Previous in villo studies have shown that both 0'2 and O'V are present 
during capillary growth. 0'2 levels are high during embryonic glo-
merular capillary formation but low in capillaries in adu lts [29], and 
avf33 has been detected in human granu lation tissue [21]. Concen-
trations of 0'2 and O'v, as well as 0'5, are upregulated by the angio-
genic factor basic fibroblast growth factor (bFGF) [30,31]. In vitro 
tube formation studies provide complex information on the role of 
a2 and O'v. Human umbilical vein endothelial cells (HUVEC) 
plated on Matrigel were inhibited from forming tubes in the pres-
ence of anti-O'v antibodies [32], whereas HUVEC plated on fibrin 
were stimulated to produce more and longer tubes in the presence of 
antibodies to O'vp3 and phorbol myristic acid [33]. Likewise, 
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HUVEC plated on collagen were stimulated by antibodies to 0'2. 
However, (Xv and 0'2 antibodies were not stimulatory when the 
substrates were reversed (HUVEC were plated on collagen and 
fibrin, respectively). Thus, in vitro tube studies cannot yet predict 
which integrins are important during in vivo angiogenesis, a process 
that depends on a complex and changing mixture of ligands. 
The finding that 0'5 and /33 are present only on a subset of micro-
vascular endothelia is consistent with previous studies in which 
0'5/31 and O'v/33 were present in granulation tissue but not quiescent 
blood vessels [21). This in turn provides further evidence that the 
microvasculature in the neonatal foreskin is undergoing active re-
modeling. The presence of the fibronectin receptor, 0'5/31, on wider 
parts of vessels but not the narrowest extensions suggests that it may 
be important at a later stage of vessel development, perhaps as cord 
cells spread and form tubes. Nicosia et af [34] found that when rat 
aortas were embedded in collagen gels, the length of outgrowing 
micro vessels increased with increasing doses of fibronectin, but the 
number of vessels did not increase. This implies that fibronectin 
does not stimulate the initial outgrowth of new vessels. 
We used several criteria to identify blood vessel sprouts. Sprouts 
were initially recognized as tapering extensions from PECAM- or 
vWF-positive vessels. To screen out cutting artifacts. we considered 
only those extensions that arose in the middle of the confocal sec-
tion series as sprouts. Because tissues were fixed before sectioning, it 
is unlikely that membranes vesiculated or solubilized. Nerves were 
initially identified by their reaction with antibodies to the 200-kDa 
neurofilament protein and subsequently by their shape and location. 
Nerves in the papillary dermis are generally thinner than blood 
vessels and extend for long distances without tapering. Because 
nerves may also wrap around blood vessels, we carefully examined 
confocal sections to ensure that the "sprout" extensions arose con-
tinuously from the full body of the vessel, rather than from a thin 
fiber running alongside. Extensions from distinctly bipolar or mul-
tiarmed cells were likewise discounted as potential sprouts, because 
they were likely to be pericytes or dermal cells. Remodeling of the 
neonatal circulation entails both growth and regression of blood 
vessels. Without a marker for regression, it is impossible to be cer-
tain whether a vessel is growing or regressing. Despite careful elim-
ination of alternative possibilities, we recognize that what we 
present is the strong suggestion of blood vessel sprouts. Without a 
definitive chemical marker of sprouts, proof of the location of 
various integrins on vessel sprouts awaits an immunoelectronmi-
croscopic study. 
What we have described is a static vision of the vessel sprouts. 
Although 0'6 and /34 were consistently the most intensely staining 
integrins at the ends of sprouts, this does not diminish the impor-
tance of other integrins, which may be present in low concentration 
and/or appear transiently at critical moments of angiogenesis. The 
integrin concentration needed to respond to the original angiogenic 
stimuli, and perhaps to recruit other integrins, may be much smaller 
than that needed to anchor the sprout physically. Whether 0'6 and 
/34 provide both signals and adhesiveness has yet to be determined. 
Note Added ill Proof Recently it has been reported that av/33 inte-
grin is required for angiogenesis in the chick chorioallantoic mem-
brane (Brooks PC, Clark RA, Cheresh DA: Requirement of vascu-
lar integrin alpha v beta 3 for angiogenesis. Science 264:569-571, 
1994). 
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